EAGLE PHARMACEUTICALS, INC. Quarterly Operating Lease, Liability in USD from Q4 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Eagle Pharmaceuticals, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2019 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Operating Lease, Liability for the quarter ending June 30, 2023 was $2.26M, a 39.4% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $2.26M -$1.47M -39.4% Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 $2.64M -$1.26M -32.3% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $3.04M -$1.17M -27.8% Dec 31, 2022 10-K 2023-03-23
Q3 2022 $3.38M -$865K -20.4% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $3.73M -$802K -17.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $3.9M -$912K -19% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $4.21M -$869K -17.1% Dec 31, 2021 10-K 2022-03-08
Q3 2021 $4.25M +$285K +7.19% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $4.53M Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $4.81M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $5.08M +$981K +23.9% Dec 31, 2020 10-K 2021-03-05
Q3 2020 $3.96M Sep 30, 2020 10-Q 2020-11-02
Q4 2019 $4.1M Dec 31, 2019 10-Q 2020-11-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.